TriSalus Life Sciences Files Definitive Proxy Statement
Ticker: TLSIW · Form: DEF 14A · Filed: Jul 19, 2024 · CIK: 1826667
| Field | Detail |
|---|---|
| Company | Trisalus Life Sciences, Inc. (TLSIW) |
| Form Type | DEF 14A |
| Filed Date | Jul 19, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
TriSalus Life Sciences filed its DEF 14A proxy statement. Standard shareholder comms.
AI Summary
TriSalus Life Sciences, Inc. filed a Definitive Proxy Statement (DEF 14A) on July 19, 2024. The filing pertains to the company's proxy materials, indicating it is a standard regulatory submission for shareholder communication. The company, formerly known as MedTech Acquisition Corp until September 30, 2020, is based in Westminster, Colorado.
Why It Matters
This filing is a routine but essential step for public companies to communicate with shareholders regarding important matters, such as annual meetings and voting procedures.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- TriSalus Life Sciences, Inc. (company) — Registrant
- MedTech Acquisition Corp (company) — Former company name
- 20240719 (date) — Filing date
- 20200930 (date) — Date of former company name change
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing detailed information about the matters to be voted upon.
When was TriSalus Life Sciences, Inc. formerly known as MedTech Acquisition Corp?
TriSalus Life Sciences, Inc. was formerly known as MedTech Acquisition Corp until September 30, 2020.
What is the filing date of this DEF 14A statement?
The filing date of this DEF 14A statement is July 19, 2024.
Where is TriSalus Life Sciences, Inc. located?
TriSalus Life Sciences, Inc. is located at 6272 West 91st Avenue, Westminster, Colorado, 80031.
What is the SIC code for TriSalus Life Sciences, Inc.?
The Standard Industrial Classification (SIC) code for TriSalus Life Sciences, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 4,890 words · 20 min read · ~16 pages · Grade level 12.8 · Accepted 2024-07-19 16:48:15
Key Financial Figures
- $10,000 — pect to pay Morrow Sodali, LLC a fee of $10,000 plus reasonable expenses for these serv
Filing Documents
- trisalus-2024formproxyx711.htm (DEF 14A) — 1304KB
- a10.jpg (GRAPHIC) — 30KB
- a2.jpg (GRAPHIC) — 29KB
- a3.jpg (GRAPHIC) — 28KB
- a4.jpg (GRAPHIC) — 50KB
- a5.jpg (GRAPHIC) — 32KB
- a6.jpg (GRAPHIC) — 32KB
- a7.jpg (GRAPHIC) — 9KB
- a9.jpg (GRAPHIC) — 27KB
- pic1.jpg (GRAPHIC) — 14KB
- proxycard.jpg (GRAPHIC) — 117KB
- proxycard2.jpg (GRAPHIC) — 83KB
- seanmurphy2.jpg (GRAPHIC) — 42KB
- trisalus_bodheadshotxmarys.jpg (GRAPHIC) — 45KB
- 0001826667-24-000034.txt ( ) — 2046KB
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 33 Summary Compensation Table 33 Narrative Disclosure Summary Compensation Table 34 Ou t standing Equity Awards 36 Employment Arrangements with Executive Officers 38 Potential Payments 38 Non-Employee Director Compensation 40 Non-Employee Director Compensation Policy 41 Equity Incentive Plans 42 Emerging Growth Company 47 EQUITY COMPENSATION PLAN INFORMATION .................................................................................................... 47
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 48 DELINQUENT SECTION 16 51 2 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 52 Policies and Procedures for Related Person Transactions 52 Certain Related Person Transactions 52 OTHER INFORMATION FOR STOCKHOLDERS 57 Stockholder Proposals for the 2025 Annual Meeting of Stockholders 57 Householding of Proxy Materials 57 Additional Filings 57 OTHER MATTERS 58 PROXY CARD 59 3 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why am I receiving these materials We have sent you these proxy materials because the Board of Directors (the "Board") of TriSalus Life Sciences, Inc. (sometimes referred to as the "Company" or "TriSalus") is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders, including at any adjournments or postponements of the meeting. You are invited to attend the annual meeting online to vote on the proposals described in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete and return the enclosed proxy card or follow the instructions below to submit your proxy over the phone or through the internet. We intend to first mail these proxy materials to all stockholders of record entitled to vote at the annual meeting on or about July 22, 2024. How do I attend the Annual Meeting This year's Annual Meeting will be a virtual meeting, which will be conducted entirely online via audio webcast to allow greater participation. You may attend, vote and ask questions at the Annual Meeting by following the instructions provided on the proxy card or voting instruction form to log in to httpswww.cstproxy.comtrisaluslifesci2024. If you are a stockholder of record, you will be asked to provide the control number from your proxy card. If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, follow the instructions from your bro